3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Kidney Failure, Chronic
1
Endometrial Neoplasms
1
End Stage Liver Disease
1
Death
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Kidney Transplantation
3
Standard of Care
2
tocilizumab
1
peginesatide
1
orellanine
1
hematide
1
carfilzomib
1
belantamab mafodotin
1
Sitagliptin Phosphate
1
Practice Guidelines as Topic
1
Pancreatectomy
1
Palliative Care
1
Massage
1
Mass Screening
1
Immunoglobulin G
1
Duration of Therapy
1
Disulfides
1
Cyclosporine
1
Cyclophosphamide
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Failure, Chronic
×
Mass Screening
×
Genitourinary
×
Clear all
NCT04143230
2019-10-29
SST2017
A.O.U. Città della Salute e della Scienza
Phase NA
Completed
660 enrolled